[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351148-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351148-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clot-composition-analysis-in-ischemic-stroke-of-cancer-patients-a-systematic-review","Clot composition analysis in ischemic stroke of cancer patients - a systematic review","","Cancer patients face elevated risk of ischemic stroke and poorer outcomes, and endovascular thrombectomy now enables analysis of retrieved clots. This systematic review identified published studies and case reports on pathological clot analysis from ischemic stroke in cancer patients, following PRISMA guidelines and searching PubMed/MEDLINE and SCOPUS under the PROSPERO registry CRD420251042353.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clot-composition-analysis-in-ischemic-stroke-of-cancer-patients-a-systematic-review/351148/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clot-composition-analysis-in-ischemic-stroke-of-cancer-patients-a-systematic-review/351148.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of this systematic review?","Question",{"text":63,"@type":64},"To identify studies and case reports describing pathological clot analysis in cancer patients with ischemic stroke, using retrieved clots from endovascular thrombectomy or material from autopsy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were studies selected for inclusion?",{"text":68,"@type":64},"PubMed/MEDLINE and SCOPUS were searched systematically under PRISMA guidelines, including pathological analyses of clots retrieved from ischemic stroke patients with cancer, while excluding children, other retrieved materials, benign tumors, or studies without cancer patient results.",{"name":70,"@type":61,"acceptedAnswer":71},"What clot characteristics were most commonly reported in cancer patients?",{"text":72,"@type":64},"Many clots showed atypical white appearance, with tumor cells or mucin in tumor or mucin embolism cases, or platelet predominance in cancer-related thrombosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351148,1790148055,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Aloizou etal. BMC Neurology (2026) 26:137 [https://doi.org/10.1186/s12883-026-04739-2](https://doi.org/10.1186/s12883-026-04739-2)  \nBMC Neurology  \nSYSTEMATIC REVIEW Open Access  \nClot composition analysis in ischemic stroke of cancer patients: a systematic review  \nAthina-Maria Aloizou1*, David-Dimitrios Chlorogiannis2, Kalliopi Pitarokoili 1,3, Dimitra Aloizou4, Jeyanthan Charles James1, Sarah Vandelanotte5, Ralf Gold1,3, Simon de Meyer5 and Christos Krogias3,6  \nAbstract  \nBackground Cancer patients are at high risk of ischemic stroke (IS) and worse outcomes. Endovascular thrombectomy (EVT) has made the analysis of retrieved clots available. This review aimed to identify studies and case reports on IS clot analysis in cancer patients (PROSPERO Registry Number CRD420251042353) .  \nMethods The databases of PubMed/MEDLINE and SCOPUS were systematically searched for studies and case reports involving pathological analysis of clots (from EVT or autopsy) retrieved from IS patients with cancer, following the PRISMA guidelines. Studies on children, other retrieved materials, benign tumors, or where the results of cancer patients were unavailable were excluded.  \nResults 23 case reports and 10 studies with larger clot numbers were included. Seventeen case reports referred to tumor embolism, 3 to cancer-related thrombosis (Trousseau syndrome), 2 to mucin embolism, and 1 to post-radiation stenosis. Most clots had an atypical white appearance, with tumor cells and mucin in tumor or mucin embolism respectively, or a platelet predominance for cancer-related thrombosis. Seven of 8 larger-scale studies reported significantly higher platelet and lower red blood cell proportions for clots in cancer patients, and 5 studies showed no increased percentages of white blood cells or neutrophil extracellular traps.  \nConclusion The available studies were heterogeneous, and relatively small. However, preponderance of studies shows the clots of cancer patients tend to be white and predominantly platelet-rich. Atypical appearances also occur in cases of tumor or mucin embolism. These findings bear diagnostic and therapeutic implications after IS in cancer patients, including tumor work-up in platelet-rich clots and no other identifiable cause.  \nKeywords Ischemic stroke, Endovascular thrombectomy, Clot, Thrombus, Cancer-related stroke, Cancer  \n*Correspondence:  \nAthina-Maria Aloizou  \n[athina-maria.aloizou@ruhr-uni-bochum.de](athina-maria.aloizou@ruhr-uni-bochum.de)  \n1Department of Neurology, St. Josef-Hospital, University Hospital of the Ruhr University Bochum, Gudrunstr 56, Bochum 44791, Germany 2Department of Internal Medicine, Mt. Auburn Hospital, Harvard Medical School, Cambridge, MA, USA  \n3Medical Faculty, Ruhr University Bochum, Bochum, Germany 4Department of Nursing, National and Kapodistrian University of Athens, Athens, Greece  \n5Laboratory for Thrombosis Research, KU Leuven, Kortrijk, Belgium 6Department of Neurology, Evangelisches Krankenhaus Herne, Academic Teaching Hospital of the Ruhr University Bochum, Bochum, Germany  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http:/","cbCaiceIP1OJJvFL","https://ap.wps.com/l/cbCaiceIP1OJJvFL","pdf",1024752,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the goal of this systematic review?\",\"answer\":\"To identify studies and case reports describing pathological clot analysis in cancer patients with ischemic stroke, using retrieved clots from endovascular thrombectomy or material from autopsy.\"},{\"question\":\"How were studies selected for inclusion?\",\"answer\":\"PubMed/MEDLINE and SCOPUS were searched systematically under PRISMA guidelines, including pathological analyses of clots retrieved from ischemic stroke patients with cancer, while excluding children, other retrieved materials, benign tumors, or studies without cancer patient results.\"},{\"question\":\"What clot characteristics were most commonly reported in cancer patients?\",\"answer\":\"Many clots showed atypical white appearance, with tumor cells or mucin in tumor or mucin embolism cases, or platelet predominance in cancer-related thrombosis.\"}]","Clot composition analysis in ischemic stroke of cancer patients - a systematic review | PDF",1790092823,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b417ce4350b2dcbcbdea07b53450190.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4bcf4f6cee237bd95bc0ba011b9584d.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63003431890b6414dc092a0541556e32.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8febb2a6525e2d1fbd2685beb282b37e.webp",980,1306]